For research use only. Not for therapeutic Use.
INX-SM-56（Cat No.:I043514）is a novel investigational compound being studied for its potential therapeutic applications in cancer treatment. It works by targeting specific molecular pathways involved in tumor cell growth, survival, and metastasis. INX-SM-56 is designed to inhibit key proteins or enzymes that contribute to the progression of cancers, especially those resistant to conventional therapies. Through its mechanism of action, INX-SM-56 aims to reduce tumor growth, enhance immune system activity, and increase the effectiveness of existing cancer treatments. Clinical studies are ongoing to assess its safety, efficacy, and therapeutic potential.
| CAS Number | 2734878-18-1 |
| Synonyms | (1S,2S,4R,6S,8S,9S,11S,12S,13R)-6-[2-[(3-aminophenyl)methyl]-1,3-thiazol-5-yl]-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one |
| Molecular Formula | C32H36N2O6S |
| Purity | ≥95% |
| IUPAC Name | (1S,2S,4R,6S,8S,9S,11S,12S,13R)-6-[2-[(3-aminophenyl)methyl]-1,3-thiazol-5-yl]-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one |
| InChI | InChI=1S/C32H36N2O6S/c1-30-9-8-20(36)12-18(30)6-7-21-22-13-26-32(25(38)16-35,31(22,2)14-23(37)28(21)30)40-29(39-26)24-15-34-27(41-24)11-17-4-3-5-19(33)10-17/h3-5,8-10,12,15,21-23,26,28-29,35,37H,6-7,11,13-14,16,33H2,1-2H3/t21-,22-,23-,26+,28+,29-,30-,31-,32+/m0/s1 |
| InChIKey | NJJMSRHGOQXBCC-WNDHDDCZSA-N |
| SMILES | C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1C[C@@H]4[C@]2(O[C@H](O4)C5=CN=C(S5)CC6=CC(=CC=C6)N)C(=O)CO)CCC7=CC(=O)C=C[C@]37C)O |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
